During Monday’s trade, Shares of Ball Corporation (NYSE:BLL), lost -0.35% to $71.10.
Ball Corporation (BLL), the premier global supplier of metal aerosol containers is now manufacturing G3-HD, a two-piece, lightweight steel aerosol container. This latest addition to Ball’s industry leading aerosol can portfolio is manufactured in the company’s Chestnut Hill, Tennessee facility. Ball presently has strong customer interest in this new, innovative packaging solution and household goods consumers can expect to see the product hitting retail shelves in 2016.
G3-HD is Ball’s next generation of steel aerosol packaging. The integrated dome design is the product of a high speed, coil-to-can manufacturing process and features high definition graphics to meet customers’ growing expectations for their brands. Moving beyond traditional steel aerosol manufacturing, G3-HD is designed to control sidewall thickness to accommodate various specifications.
“Ball’s G3-HD demonstrates our on-going commitment to innovative packaging solutions that assist our customers grow their business,” said Jim Peterson, senior vice president and chief operating officer, global metal food and household products packaging.
Ball Corporation, together with its auxiliaries, supplies metal packaging products to the beverage, food, personal care, and household products industries worldwide. It operates in four segments: Metal Beverage Packaging, Americas and Asia; Metal Beverage Packaging, Europe; Metal Food and Household Products Packaging; and Aerospace and Technologies.
Shares of Viavi Solutions Inc (NASDAQ:VIAV), declined -1.20% to $5.75, during its current trading session.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Geron Corp. (GERN), MaxLinear Inc. (MXL), Halozyme Therapeutics Inc. (HALO) and Viavi Solutions Inc. (VIAV). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Wednesday, December 9, 2015, Nasdaq Composite ended at 5,022.87, down 1.48%, Dow Jones Industrial Average declined 0.43%, to finish the day at 17,492.30, and the S&P 500 closed at 2,047.62, down 0.77%
- Geron Corp.’s stock slipped by 5.91% to close Wednesday’s session at USD 4.46. The company’s shares oscillated between USD 4.42 and USD 4.80. The stock recorded a trading volume of 3.30 million shares, which was above its 50-day daily average volume of 2.77 million shares and above its 52-week average volume of 3.01 million shares. Over the last five days, Geron Corp.’s shares have declined by 11.68% while in the past one month, the stock has gained a momentum of 14.36%. In addition, over the last three months, the stock has gained 38.08% and year to date, the shares have picked up 37.23%. The company has returned 12.34% in the past one month, and 32.34% in the past one year, on a compounded total return basis. The stock is at a price to book ratio of 5.07. The historical PB ratio is near to 3.91. Additionally, the stock is trading at a price to sales ratio of 20.64.
- MaxLinear Inc.’s stock declined 5.13% to close Wednesday’s session at USD 16.29. The share price vacillated between USD 16.13 and USD 17.19. The stock recorded a trading volume of 0.87 million shares, which was below its 50-day daily average volume of 1.05 million shares and above its 52-week average volume of 0.55 million shares. Over the last three days MaxLinear Inc.’s shares have declined by 5.24% and in the past one week the stock has moved down 4.06%. However, in the last six months, the stock has gained 33.52% and year to date, the shares have picked up 119.84%. On a compounded total return basis, the company has returned 32.76% in the last half a year, and 106.20% in the past one year. The stock is at a price to book ratio of 3.99. The historical PB ratio is near to 2.83. Additionally, the stock is trading at a price to cash flow ratio of 28.92 and at a price to sales ratio of 4.02.
- Halozyme Therapeutics Inc.’s stock edged lower by 4.40% to close Wednesday’s session at USD 16.29. The company’s shares oscillated between USD 16.07 and USD 16.98. The stock recorded a trading volume of 0.87 million shares, which was below its 50-day daily average volume of 1.26 million shares and below its 52-week average volume of 1.52 million shares. Over the last three days, Halozyme Therapeutics Inc.’s shares have declined by 7.39% and in the past one week the shares have moved down 7.55%. However, year to date the stock has gained 68.81%. The stock is trading 3.64% below its 20-day simple moving average and 7.54% below its 200-day simple moving average. Further the stock is at a price to book ratio of 68.49. The historical PB ratio is near to 29.34. Moreover, Halozyme Therapeutics Inc.’s shares have a Relative Strength Index of 47.23.
- The stock of Viavi Solutions Inc. lost 1.30% to close Wednesday’s session at USD 6.06. The shares of the company moved in the range of USD 5.95 and USD 6.21. A trading volume of 2.30 million shares was recorded, which was lower than its 150-day daily average volume of 3.28 million shares and below its 52-week average volume of 3.83 million shares. Over the last five days, Viavi Solutions Inc.’s shares have declined by 3.81% and in the past one month, the shares have lost 7.20%. Additionally, over the last three months, the stock has advanced 8.99% while in the past six months, the shares have registered a loss of 17.98%. Further the stock is having a 52 week range of USD 4.99 - USD 8.10. Moreover, Viavi Solutions Inc.’s stock is trading 3.42% below its 20-day simple moving average and 8.17% below its 200 day simple moving average.
Viavi Solutions Inc. engages in the network enablement, service enablement, and communications and commercial optical products businesses. The company’s Network Enablement segment provides an integrated portfolio of testing solutions that access the network to perform build out and maintenance tasks. This segment’s solutions comprise instruments, software, and services to design, build, turn-up, certify, troubleshoot, and optimize networks.
Finally, ACE Limited (NYSE:ACE), gained 0.86%, and is now trading at $114.09.
Healthcare-associated infections (also known as HAIs) contribute to a startling 99,000 patient deaths annually1 and alone account for $30 billion a year in U.S. healthcare costs.2 Just as there are various ways healthcare-associated infections can be attained, liability for healthcare organizations and professionals can occur in many different situations, making HAIs an ever-present safety risk both in terms of patient injury and related financial risk. ACE Group declared the release of an in-depth advisory on the risks associated with healthcare-associated infections and how healthcare organizations can assist protect patients and themselves against potential hazards and liabilities.
“Healthcare-Associated Infections: A Deeper Look” was co-authored by Diane Doherty, Vice President and Edward Dunn, Vice President, ACE Medical Risk Group. This report is the latest installment in ACE’s series of insurance and risk administration perspectives for risk managers.
“According to the World Health Organization, seven out of every 100 hospitalized patients at any given time will acquire at least one healthcare-associated infection,” said Ms. Doherty. “As this trend is on the rise, it is important that healthcare organization’s put patient safety first. In addition to clinical risks, healthcare leaders must understand the threats healthcare-associated infections pose to their organizations’ financial well-being and reputation. Developing effective prevention strategies, a comprehensive risk administration plan and ensuring the appropriate insurance coverage is in place will assist to combat healthcare-associated infections and keep healthcare organization’s one step ahead.”
ACE Limited, through its auxiliaries, provides a range of property and casualty insurance and reinsurance products worldwide. The company’s Insurance North American P&C segment offers casualty insurance, environmental, inland marine, professional risk, disaster protection, vacant land and building, and claims and risk administration services; homeowners, automobile, valuables, umbrella liability, and recreational marine insurance; and wholesale excess and surplus lines property, casualty, environmental, professional liability, inland marine, and product recall coverages.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
